Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

223.66
-5.0650-2.21%
Volume:3.13M
Turnover:702.00M
Market Cap:395.28B
PE:94.77
High:229.37
Open:228.72
Low:223.02
Close:228.72
52wk High:244.81
52wk Low:164.39
Shares:1.77B
Float Shares:1.76B
Volume Ratio:0.45
T/O Rate:0.18%
Dividend:6.65
Dividend Rate:2.97%
EPS(TTM):2.36
EPS(LYR):2.36
ROE:1106.67%
ROA:9.59%
PB:-149.62
PE(LYR):94.77

Loading ...

Daiwa Securities Raises AbbVie Price Target to $244 From $226, Maintains Outperform Rating

MT Newswires Live
·
4 hours ago

AbbVie Keeps Quarterly Dividend at $1.73 a Share, Payable May 15 to Shareholders of Record on April 15

MT Newswires Live
·
Yesterday

Press Release: AbbVie Declares Quarterly Dividend

Dow Jones
·
Yesterday

AbbVie Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Yesterday

AbbVie’s ABBV-547 First‑in‑Human Trial: What Early Pipeline Moves Mean for ABBV Investors

TIPRANKS
·
Yesterday

AbbVie’s VOLITE Skin Quality Trial Completion: What It Means for ABBV Investors

TIPRANKS
·
Yesterday

Tarsus Pharmaceuticals Names Former Allergan CEO David Pyott to Board

Reuters
·
Feb 18

AbbVie Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Feb 18

BRIEF-Mubadala Investment Co Pjsc Reports Share Stake In Pfizer, Abbvie, Dissolves in Merck, Dell

Reuters
·
Feb 18

HSBC Adjusts Price Target on AbbVie to $275 From $265, Maintains Buy Rating

MT Newswires Live
·
Feb 17

AbbVie Advances New Toxin-Based Therapy in Ventral Hernia Trial: What Investors Should Watch

TIPRANKS
·
Feb 14

Nxera Pharma Unveils Corporate Presentation Highlighting Global Strategy and Drug Discovery Platform

Reuters
·
Feb 13

AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 13

AbbVie’s Korean Rinvoq Study Wraps Up, Bolstering Real-World Data for Immunology Growth

TIPRANKS
·
Feb 13

West Pharma forecasts 2026 profit above estimates on strong demand for drug components

Reuters
·
Feb 12

Abbvie Sues U.S. Department of Health and Human Services Over Selection of Botox for Ira Medicare Drug Negotiations

THOMSON REUTERS
·
Feb 12

Abbvie sues US health agency over Botox

Reuters
·
Feb 12

Neurocrine Biosciences Q4 GAAP other income rises 38% to USD 28.5 million

Reuters
·
Feb 12

AbbVie Updates Phase 2 Elezanumab Study in Acute Cervical Spinal Cord Injury: What Investors Should Watch

TIPRANKS
·
Feb 12

AbbVie’s Real-World Migraine Study Could Quietly Boost Ubrogepant’s Market Potential

TIPRANKS
·
Feb 11